News Conference News ESC 2019 LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17 Todd Neale September 10, 2019
News Conference News ESC 2019 TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization L.A. McKeown September 09, 2019
News Conference News ESC 2019 For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI Todd Neale September 03, 2019
News Conference News ESC 2019 AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD Todd Neale September 02, 2019
News Conference News ESC 2019 DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics Shelley Wood September 01, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Conference News ESC 2018 Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR Shelley Wood August 28, 2018
Presentation ESC 2018 ASCEND A Randomized Trial of Omega-3 Fatty Acids (fish oil) vs Placebo Presenter: Jane Armitage August 27, 2018
Presentation ESC 2018 ASCEND Randomized placebo-controlled trial of aspirin Presenter: Jane Armitage August 27, 2018
News Conference News ESC 2018 COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure Todd Neale August 27, 2018
News Conference News ESC 2018 ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients Todd Neale August 26, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Opinion Editor's Corner ESC 2017 My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back Shelley Wood September 08, 2017
News Conference News ESC 2017 EMANATE: Another NOAC Shown to Be Safe, Effective in the Setting of Cardioversion for A-fib Todd Neale September 05, 2017
News Conference News ESC 2017 Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death Yael L. Maxwell September 01, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016